Deformation patterns in genotyped patients with hypertrophic cardiomyopathy

Jeffrey B Geske1, J Martijn Bos, Bernard J Gersh

  • 1Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA.

Insights

Echocardiographic strain imaging reveals that septal thickness, not genetic mutation status, dictates regional strain differences in hypertrophic cardiomyopathy (HCM) patients. These findings highlight heterogeneous phenotypic expression in HCM.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Genetics

Background:

  • Echocardiographic strain imaging is an emerging tool for assessing cardiac function and identifying preclinical hypertrophic cardiomyopathy (HCM).
  • A reverse septal contour is a known predictor of mutation-positive sarcomeric HCM.
  • Left ventricular (LV) deformation patterns may help differentiate between genotype-positive and negative HCM patients.

Purpose of the Study:

  • To determine if LV deformation patterns can differentiate between genotype-positive and genotype-negative patients in a large HCM cohort.
  • To investigate the relationship between septal morphology, thickness, and LV strain patterns in HCM.
  • To understand the phenotypic expression of HCM based on genetic status and cardiac structure.

Main Methods:

  • Comprehensive transthoracic echocardiography with LV strain imaging was performed on 131 clinically diagnosed HCM patients.
  • Genotyping for nine myofilament HCM-associated genes was conducted.
  • Longitudinal peak systolic strain was assessed in 17 LV myocardial segments and correlated with septal morphology and thickness.

Main Results:

  • 39% of HCM patients were mutation-positive for sarcomeric HCM (genotype-positive).
  • Regional strain was significantly lower in genotype-positive patients in specific septal segments.
  • However, no significant regional strain differences were found when comparing genotype-positive and negative patients with similar septal morphology.
  • Septal thickness positively correlated with global and basal anteroseptal longitudinal strain.

Conclusions:

  • Regional strain differences in genotyped HCM patients are primarily dependent on septal morphology and thickness, not genotype.
  • The phenotypic expression of cardiac deformation patterns in HCM is heterogeneous.
  • Septal morphology and thickness are crucial factors in interpreting strain imaging findings in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957